A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
NCT03240523
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
766
Enrollment
INDUSTRY
Sponsor class
Stopped
Due to a change in the development program, the study was closed prematurely.
Conditions
Uterine Fibroids
Interventions
DRUG:
Vilaprisan (BAY1002670)
Sponsor
Bayer